BPC 157 Erectile Dysfunction Study: What the Evidence Actually Shows Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics ScienceDirect BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts 1209_S7_article_14 What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B Therapeutic peptides and proteins: Status and developments in drug delivery ScienceDirect